About Us
We develop, manufacture, and market proven and innovative medicines, focusing on advanced drug delivery technologies that improve patient experience and outcomes.
Founded in 1836, Acino has a global presence, serving patients in Africa, Latin America, the Middle East, Türkiye, Ukraine, and the Eurasian market. In Saudi Arabia, we are a market leader in modified‑release and orally dispersible technologies, with a deep therapeutic expertise in gastroenterology, pain management, cardiovascular health, neurosciences, and infectious diseases care.
With over 20 years’ of experience in the Kingdom, Acino KSA combines local insight with global capabilities. Through strategic partnerships and alignment with Saudi Vision 2030, we are committed to advancing sustainable healthcare and expanding access to high‑quality medicines.
Advancing with Arcera
Acino is part of Arcera, a global company in the life sciences sector headquartered in Abu Dhabi, United Arab Emirates.
Arcera was established by ADQ, an Abu Dhabi-based investment and holding company, to build a global life sciences powerhouse poised to make significant contributions to realising the UAE’s aspiration to emerge as a frontrunner in science and technology.
To learn more about Arcera, please visit www.arceralifesciences.com.
